BTIG analyst Ryan Zimmerman maintained a Hold rating on AxoGen (AXGN – Research Report) today. The company's shares closed last Monday at $8.76, close to its 52-week low of $6.87. According to TipRanks.com, Zimmerman is a 4-star analyst with an average return of 7.4% and a 44.1% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Treace Medical Concepts, and Zimmer Biomet Holdings. Currently, the analyst consensus on AxoGen is a Strong Buy with an average price target of $17.50.
https://www.tipranks.com/news/blurbs/btig-remains-a-hold-on-axogen-axgn?utm_source=advfn.com&utm_medium=referral
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Axogen Charts.
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Axogen Charts.